切换至 "中华医学电子期刊资源库"
高级检索
中华肺部疾病杂志(电子版)

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (03) : 289 -295. doi: 10.3877/cma.j.issn.1674-6902.2019.03.005

所属专题： 文献；

论著

肺纤维化合并肺气肿综合征并发肺动脉高压的Meta分析
石涵宇1, 董彦2,†(), 魏路清3, 殷大伟3, 宗庆芸4   
  1. 1. 300162　天津，中国人民武装警察部队特色医学中心呼吸与重症医学科；300309　天津，武警后勤学院
    2. 300162　天津，中国人民武装警察部队特色医学中心超声心动图室
    3. 300162　天津，中国人民武装警察部队特色医学中心呼吸与重症医学科
    4. 300162　天津，天津下瓦房医院；300309　天津，武警后勤学院
  • 收稿日期:2018-07-10 出版日期:2019-06-20
  • 通信作者: 董彦
  • 基金资助:
    天津市自然科学基金资助项目(15JCZDJC35000)

Systematic review and meta-analysis on pulmonary hypertension in patients with combined fibrosis and emphysema syndrome

Hanyu Shi1, Yan Dong2,†(), Luqing Wei3, Dawei Yin3, Qingyun Zong4   

  1. 1. Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Logistics University of Chinese People′s Armed Police Forces, Tianjin 300162, China; Armed Police Logistics College, Tianjin 300309, China
    2. Department of Ultrasound, Affiliated Hospital of Logistics University of Chinese People′s Armed Police Forces, Tianjin 300162, China
    3. Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Logistics University of Chinese People′s Armed Police Forces, Tianjin 300162, China
    4. Hospital of Xiawafang, Tianjin 300162, China; Armed Police Logistics College, Tianjin 300309, China
  • Received:2018-07-10 Published:2019-06-20
  • Corresponding author: Yan Dong
  • About author:
    Corresponding author: Dong Yan, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

石涵宇, 董彦, 魏路清, 殷大伟, 宗庆芸. 肺纤维化合并肺气肿综合征并发肺动脉高压的Meta分析[J/OL]. 中华肺部疾病杂志(电子版), 2019, 12(03): 289-295.

Hanyu Shi, Yan Dong, Luqing Wei, Dawei Yin, Qingyun Zong. Systematic review and meta-analysis on pulmonary hypertension in patients with combined fibrosis and emphysema syndrome[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(03): 289-295.

目的

系统评价肺纤维化合并肺气肿(CPFE)综合征与特发性肺纤维化(IPF)或肺气肿/COPD相比肺动脉高压的发生率及肺动脉压力水平。

方法

计算机检索CBM、CNKI(中国知网)、Wan Fang Data(万方数据库)、VIP(维普)、PubMed、Embase及Cochrane Library，查找报道肺纤维化合并肺气肿综合征的全部文献，检索时间为2005年至2018年1月。由两位评价员按照纳入排除标准分别筛选文献，提取数据、评估文献，采用Revman5.3及Stata14.0软件进行分析。

结果

纳入13篇文献，共1 385例患者。Meta结果分析表明：CPFE综合征与独立存在的IPF相比，无论是肺动脉高压发生率[OR＝1.93，95%CI(1.17，3.17)，P＝0.010]还是肺动脉压力水平[MD＝11.89，95%CI(7.39，16.39)，P<0.00001]都较高而且存在统计学差异。CPFE综合征与肺气肿/COPD相比，肺动脉高压的发生率[OR＝2.62，95%CI(1.42，4.81)，P＝0.002]及肺动脉压力水平[MD＝7.49，95%CI(5.27，9.72)，P<0.00001]也较高且具有显著差异。

结论

CPFE综合征与IPF相比，肺动脉高压发生率及肺动脉压力水平均较高；CPFE综合征与肺气肿/COPD相比，肺动脉高压发生率及肺动脉压力水平也较高。CPFE综合征更容易并发肺动脉高压且更严重，对CPFE综合征患者应定期监测肺动脉压力从而实现早期诊断及治疗。

关键词: 肺纤维化, 肺气肿, 肺动脉高压, Meta分析, 系统分析
Objective

To evaluate systematically the incidence and the level of pulmonary hypertension in the patients with combined pulmonary fibrosis with emphysema (CPFE) syndrome compared with those of the patients with idiopathic pulmonary fibrosis (IPF) or pulmonary emphysema/chronic obstructive pulmonary disease (COPD).

Methods

All the reports about CPFE syndromes were collected by searching these databases including CBM, CNKI, Wan Fang Data, VIP, PubMed, Embase and the Cochrane library (12th in 2017) from January 2005 to January 2018. All the titles/abstracts were reviewed to identify the possible studies with predefined selection criteria. All the data were combined and analyzed using Review Manager 5.3 or Stata 14.0.

Results

A total of 1 385 patients included in 13 reports were selected for this meta-analysis. Compared with the IPF group, the CPFE group had a higher incidence [OR=1.93, 95%CI (1.17, 3.17), P=0.010] and a higher level [MD=11.89, 95%CI (7.39, 16.39), P<0.00001] of pulmonary hypertension. Meanwhile, the incidence [OR=2.62, 95%CI (1.42, 4.81), P=0.002] and the level [MD=7.49, 95%CI (5.27, 9.72), P<0.00001] of pulmonary hypertension also presented higher results compared with the pulmonary emphysema/COPD group.

Conclusion

CPFE syndrome manifests a higher incidence and a higher level of pulmonary hypertension when compared with the IPF group as well as the pulmonary emphysema/COPD group and should be monitored regularly.

Key words: Fibrosis, Pulmonary Emphysema, Pulmonary hypertension, Meta-analysis, Systematic review
图1 文献筛选流程及结果
表1 纳入研究的基本资料特征
作　者 研究周期(年) 年龄(CPFE/对照) 研究类型 研究地点 对照组疾病 CPFE(例数) 对照组(例数) 结局指标
赵丽娜2016[8] 3 71.38±10.14/68.53±7.64 CC 中国，吉林 IPF 21 30 ①②
陈锋2016[12] 6 71.23±7.03/69.96±7.85 Cohort 中国，北京 IPF 21 26 ①②
秦文婧2016[7] 2 85.1±10.6/63.9±8.6/73.9±11.4 CC 中国，河南 IPF＋COPD 34 78(IPF)41(COPD) ①②③④
陈恒屹2014[21] 3 68.7±4.1/71.1±6.0 Cohort 中国，重庆 IPF 31 36 ②
谭晓明2013[23] 12 84.11±11.00/74.84±13.46/70.86±7.70 CC 中国，北京 IPF＋COPD 55 40(IPF)55(COPD) ①②③④
Ye2014[22] 4 64±9/66±8 CC 中国，北京 IPF 70 55 ①
Zhang2016[9] 13 66±8.5/60±4.3 Cohort 中国，哈尔滨 IPF 87 105 ①
Tomioka2016[20] 8 76.5±7.1/73.4±9.0 Cohort 日本 COPD 17 49 ④
Sugino2013[19] 7.5 71.4±6.7/73.7±6.3 Cohort 日本 IPF 46 62 ②
Sato2016[10] 3 69.1/68.7 Cohort 日本 IPF 44 38 ①
Lee2011[13] 6 71a/71 Cohort 韩国 PE 45/135 51/135 ③④
Jacob2017[11] 8 69a/69 CC 美国 IPF 171 214 ①
Mejía2009[6] 10 63±10/67±7 Cohort 墨西哥 IPF 31 79 ①
表2 纳入文献偏倚风险评价表
作　者 研究类型 研究对象选择 可比性 结果/暴露因素测量 总分
赵丽娜2016 CC ★★★ ★ ★★ 6
陈锋2016 Cohort ★★★ ★ ★★★ 7
秦文婧2016 CC ★★★ ★ ★ 5
陈恒屹2014 Cohort ★★★ ★ ★ 6
谭晓明2013 CC ★★★ ★ ★★ 6
Zhang2016 Cohort ★★★ ★ ★★★ 7
Mejia2009 Cohort ★★★ ★ ★★★ 7
Tomiaka2016 Cohort ★★★ ★ ★★★ 7
Sugino2013 Cohort ★★★ ★ ★★★ 7
Sato2016 Cohort ★★★ ★ ★★ 6
Lee2011 Cohort ★★★ ★ ★★★ 7
Jacob2017 CC ★★★ ★ ★★ 6
Ye2014 CC ★★★ ★ ★★ 6
图2 CPFE综合征与IPF肺动脉高压发生率比较的森林图
图3 CPFE综合征与IPF的肺动脉压力水平比较的森林图
图4 CPFE综合征与肺气肿/COPD肺动脉高压发生率比较的森林图
图5 CPFE综合征较肺气肿/COPD的肺动脉压力水平的森林图
1
单兆运，陈治安. 慢性阻塞性肺疾病的光镜，电镜及免疫病理研究[J]. 中华结核和呼吸杂志，1990, 13(5): 311-313.
2
Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment[J]. Respir Med, 1990, 84(5): 365-369.
3
Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity[J]. Eur Respir J, 2005, 26(4): 586-593.
4
Shlobin OA, Nathan SD. Pulmonary hypertension secondary to interstitial lung disease[J]. Expert Rev Respir Med, 2011, 5(2): 179-189.
5
D′Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry[J]. Ann Intern Med, 1991, 115(5): 343-349.
6
Mejía M, Carrillo G, Rojasserrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension.[J]. Chest, 2009, 136(1): 10-15.
7
秦文婧，梁宇，齐红松. 肺间质纤维化合并肺气肿综合征的临床特点分析[J]. 中国当代医药，2016, 23(13): 26-28.
8
赵丽娜. 肺间质纤维化合并肺气肿综合征21例临床分析[D]. 延边大学，2016: 12-22.
9
Zhang L, Zhang C, Dong F, et al. Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis[J]. Bmc Pulm Med, 2016, 16(1): 137.
10
Sato S, Tanino Y, Misa K, et al. Identification of Clinical Phenotypes in Idiopathic Interstitial Pneumonia with Pulmonary Emphysema[J]. Intern Med, 2015, 55(12): 1529-1535.
11
Jacob J, Bartholmai BJ, Rajagopalan S, et al. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema[J]. Respirology, 2018, 23(6): 593-599.
12
陈锋，张磊，唐家璇，等. 肺纤维化合并肺气肿与特发性肺纤维化的临床特征比较分析[J]. 医学理论与实践，2016, 29(10): 1263-1265.
13
Lee CH, Kim HJ, Park CM, et al. The impact of combined pulmonary fibrosis and emphysema on mortality[J]. Int J Tuberc Lung Dise, 2011, 15(8): 1111-1116.
14
Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis：evidence-based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
15
Johannessen A, Nilsen RM, Storeb M, et al. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization[J]. Am J Respir Crit Care Med, 2013, 188(1): 51-59.
16
Lau EM, Tamura Y, Mcgoon MD, et al. The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress[J]. Eur Respir J, 2015, 46(4): 879-882.
17
Mclaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association[J]. J Am Coll Cardiol, 2009 Apr 28; 53(17): 1573-619.
18
Wells GA, Shea BJ, O′Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis[J]. Applied Engineering in Agriculture, 2014, 18(6): 727-734.
19
Sugino K, Ishida F, Kikuchi N, et al. Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone[J]. Respirology, 2014, 19(2): 239-245.
20
Tomioka H, Mamesaya N, Yamashita S, et al. Combined pulmonary fibrosis and emphysema: effect of pulmonary rehabilitation in comparison with chronic obstructive pulmonary disease[J]. BMJ Open Respir Res, 2016, 3(1): e000099.
21
陈恒屹，康军，崔社怀，等. 特发性肺间质纤维化合并肺气肿的临床特征分析[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(1): 7-11.
22
Ye Q, Huang KW, Ding Y, et al. Cigarette smoking contribute to idiopathic fibrosis associated with emphysema[J]. 中华医学杂志(英文版), 2014, 127(3): 469-474.
23
谭晓明. 肺间质纤维化合并肺气肿综合征的临床特点研究[D]. 北京，北京协和医学院，2013: 32-65.
24
Cottin V, Le Pavec J, Prévot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome[J]. Eur Respir J, 2010, 35(1): 105-111.
25
Munson JC. Combined pulmonary fibrosis and emphysema: a high-pressure situation[J]. Eur Respir J, 2010, 35(1): 9-11.
26
Vargas CI, Buendiaroldan I, Avla MM, et al. Patients with Combined Pulmonary Fibrosis and Emphysema Show a Worse Heart Rate Recovery After Exercise Compared with Patients with Idiopathic Pulmonary Fibrosis[J]. Am J Respir Crit Care Med, 2015, 191: A1565.
27
Kawamukai M, Koyama M, Nishida J, et al. Prognostic evaluation of patients with pulmonary hypertension by combined non-invasive assessment of pulmonary vascular resistance and right ventricular function[J]. Eur Heart J, 2013, 34(suppl 1): 326.
28
Swift AJ, Rajaram S, Capener D, et al. S120 Right Ventricular Dysfunction In Pulmonary Hypertension With Combined Pulmonary Fibrosis And Emphysema Syndrome[J]．Thorax, 69(suppl 2): A64-A65.
29
Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions[M]. John Wiley &Sons, 2011: 38-56.
30
Cottin V, Nunes H, Bérézné A, et al. Combined Pulmonary Emphysema And Fibrosis In Connective Tissue Disease[J]. Arthritis Rheum, 2011 Jan; 63(1): 295-304.
Cottin V. Combined pulmonary fibrosis and emphysema: bad and ugly all the same？[J]. Eur Respir J, 2017, 50(1): 1700846.
32
Jankowich MD, Rounds S. Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema[J]. Lung, 2010, 188(5): 365-373.
33
张天嵩，钟文昭，徐同成. 漏斗图的绘制与不对称检验在Stata中的实现[J]. 循证医学，2009, 9(2): 110-114.
[1] 蚁淳, 袁冬生, 熊学军. 系统免疫炎症指数与骨密度降低和骨质疏松的关联[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 609-617.
[2] 李志文, 李远志, 李华, 方志远. 糖皮质激素治疗膝骨关节炎疗效的网状Meta分析[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 484-496.
[3] 吴义刚, 潘裕民, 吴姗姗, 胡梦涓, 王一为, 张劲松, 乔莉. 左西孟旦治疗肺动脉高压合并右心衰竭患者疗效分析——Meta 分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 385-391.
[4] 吴姗姗, 潘裕民, 刘晋, 张劲松, 乔莉. 睡眠呼吸暂停综合征患者静脉血栓栓塞症发生率的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 312-317.
[5] 沈皓, 张驰, 韩旻轩, 陆晓庆, 周愉, 周莉丽. 骨皮质切开术对正畸治疗牙根吸收影响的Meta分析[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(03): 175-184.
[6] 沈琪乐, 赵勤华, 宫素岗, 刘锦铭, 王岚, 邱宏玲. COPD 稳定期患者血清CC16 蛋白表达与肺功能、肺气肿表型的关系分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 690-695.
[7] 王亚岚, 倪婧, 余世庆, 陶银花, 张荣. 尼达尼布抗纤维化治疗特发性肺纤维化的耐受性和疗效预测因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 750-755.
[8] 宋新雅, 苏小慧, 卞士柱, 丁小涵. 吸入性药物治疗肺动脉高压的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 831-835.
[9] 罗霞, 王宝梅, 李淑景, 杨英. 特发性肺动脉高压血清PCSK9表达及预后意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 585-589.
[10] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[11] 龚财芳, 赵俊宇, 游川. 围手术期肠内营养在肝癌肝切除患者中有效性及安全性的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 551-556.
[12] 王芳, 刘达, 左智炜, 盛金平, 陈庭进, 蒋锐. 定量CT与双能X线骨密度仪对骨质疏松诊断效能比较的Meta分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 363-371.
[13] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[14] 周倩妹, 王宪娥, 徐筱, 老慧琳, 赵欣悦, 胡菁颖. 多元化系统护理对老年人群牙周健康指标影响的系统评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 500-506.
[15] 龚霄雷, 朱丽敏, 姜燕, 徐卓明. 急性右心室功能障碍的诊疗进展[J/OL]. 中华心脏与心律电子杂志, 2024, 12(03): 161-168.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号